Zhongzhi Pharmaceutical Holdings Limited at its 2025 annual general meeting held on 13 May 2025, approved the the declaration and payment of a final dividend of 5 Hong Kong cents per ordinary share out of the Share Premium account of the Company (the ?Final Dividend?) to shareholders of the Company whose names appeared on the register of members of the Company on the record date fixed by the board of directors (the ?Board?) for determining the entitlements to the Final Dividend be and is hereby approved.